Product NDC: | 49884-407 |
Proprietary Name: | METOPROLOL SUCCINATE |
Non Proprietary Name: | Metoprolol succinate |
Active Ingredient(s): | 200 mg/1 & nbsp; Metoprolol succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-407 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019962 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20070726 |
Package NDC: | 49884-407-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (49884-407-01) |
NDC Code | 49884-407-01 |
Proprietary Name | METOPROLOL SUCCINATE |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (49884-407-01) |
Product NDC | 49884-407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol succinate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20070726 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | METOPROLOL SUCCINATE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |